Akari Therapeutics(AKTX)

1.73 0.03 1.7647%

今开:1.69昨收:1.7
最高:1.73 最低:1.69
涨停价:0.0跌停价:0.0
总市值:6.8594137E7

Akari Therapeutics的热门评论

vichu889504-13 21:17

$Akari Therapeutics(AKTX)$ Akari Therapeutics宣布启动Nomacopan在大疱性类天疱疮(BP)中的关键性III期临床试验 ·FDA正在研究新药的申请(IND) ·预计将在2021年中期开放招募临床站点 纽约和伦敦,2021年4月12日–生物制药公司Akari Therapeutics,Plc(纳斯达克股票代码:AKTX)专注于治疗...查看全文

vichu889503-04 22:24

$Akari Therapeutics(AKTX)$ Akari Therapeutics宣布与美国陆军外科医学研究所(USAISR)达成关于创伤性Nomacopan的合作研究与开发协议(CRADA) Akari Therapeutics Plc 2021年3月4日,星期四,晚上9:30 AKTX -5.14% USAISR正在研究猪瘟和出血性休克的猪模型,这是开发使用nomacopan治疗创伤的...查看全文

Akari Therapeutics(AKTX)2020-09-14 18:06

$Akari Therapeutics(AKTX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001104659-20-104499 Act: 33 Size: 592 KB 网页链接查看全文

Akari Therapeutics(AKTX)2020-04-18 05:05

$Akari Therapeutics(AKTX)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-20-048247 Act: 33 Size: 568 KB 网页链接查看全文

Akari Therapeutics(AKTX)2020-03-31 20:35

$Akari Therapeutics(AKTX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-20-040851 Act: 34 Size: 106 KB 网页链接查看全文

Akari Therapeutics(AKTX)2020-03-31 05:00

$Akari Therapeutics(AKTX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-20-040437 Act: 34 Size: 49 KB 网页链接查看全文

Akari Therapeutics(AKTX)2020-04-17 18:10

$Akari Therapeutics(AKTX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-000774 Act: 33 Size: 1 KB 网页链接查看全文

Akari Therapeutics(AKTX)2020-04-15 18:10

$Akari Therapeutics(AKTX)$ F-3/A [Amend] Registration statement by foreign private issuers Accession Number: 0001104659-20-046475 Act: 33 Size: 706 KB 网页链接查看全文

汉尼拔大厨2020-05-21 22:30

$Akari Therapeutics(AKTX)$ 看样子,快启动了查看全文

Akari Therapeutics(AKTX)2020-03-12 04:40

$Akari Therapeutics(AKTX)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001104659-20-031954 Act: 33 Size: 14 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Akari Therapeutics的最新评论

Akari Therapeutics(AKTX)06-08 05:36

$Akari Therapeutics(AKTX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-21-077796 Act: 34 Size: 1 MB 网页链接查看全文

Akari Therapeutics(AKTX)05-03 18:18

$Akari Therapeutics(AKTX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-001646 Act: 33 Size: 1 KB 网页链接查看全文

Akari Therapeutics(AKTX)05-03 18:18

$Akari Therapeutics(AKTX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-001639 Act: 33 Size: 1 KB 网页链接查看全文

Akari Therapeutics(AKTX)05-03 18:18

$Akari Therapeutics(AKTX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-001663 Act: 33 Size: 1 KB 网页链接查看全文

Akari Therapeutics(AKTX)05-03 18:18

$Akari Therapeutics(AKTX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-001645 Act: 33 Size: 1 KB 网页链接查看全文

Akari Therapeutics(AKTX)04-29 05:36

$Akari Therapeutics(AKTX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001104659-21-056667 Act: 33 Size: 845 KB 网页链接查看全文

Akari Therapeutics(AKTX)04-29 05:27

$Akari Therapeutics(AKTX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-21-056613 Act: 34 Size: 23 KB 网页链接查看全文

Akari Therapeutics(AKTX)04-28 18:57

$Akari Therapeutics(AKTX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001104659-21-055818 Act: 33 Size: 577 KB 网页链接查看全文

Akari Therapeutics(AKTX)04-28 18:57

$Akari Therapeutics(AKTX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001104659-21-055819 Act: 33 Size: 577 KB 网页链接查看全文

Akari Therapeutics(AKTX)04-28 18:57

$Akari Therapeutics(AKTX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001104659-21-055821 Act: 33 Size: 577 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Akari Therapeutics的公告

$Akari Therapeutics(AKTX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-000780 Act: 33 Size: 1 KB 网页链接

$Akari Therapeutics(AKTX)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-20-048247 Act: 33 Size: 568 KB 网页链接

$Akari Therapeutics(AKTX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-000774 Act: 33 Size: 1 KB 网页链接

$Akari Therapeutics(AKTX)$ F-3/A [Amend] Registration statement by foreign private issuers Accession Number: 0001104659-20-046475 Act: 33 Size: 706 KB 网页链接

$Akari Therapeutics(AKTX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001104659-20-044654 Act: 33 Size: 591 KB 网页链接

$Akari Therapeutics(AKTX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-20-040851 Act: 34 Size: 106 KB 网页链接

$Akari Therapeutics(AKTX)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001104659-20-040722 Act: 34 Size: 6 MB 网页链接

$Akari Therapeutics(AKTX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-20-040437 Act: 34 Size: 49 KB 网页链接

$Akari Therapeutics(AKTX)$ F-3 Registration statement by foreign private issuers Accession Number: 0001104659-20-038458 Act: 33 Size: 586 KB 网页链接

$Akari Therapeutics(AKTX)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001104659-20-031954 Act: 33 Size: 14 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23